血管紧张素转换酶抑制剂-话题@MedSci

#血管紧张素转换酶抑制剂#

16篇内容 | 691人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1570543, encodeId=887f15e054371, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险, objectType=article, longId=739474, objectId=f928e39474c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f928e39474c7, replyNumber=0, likeNumber=28, createdTime=2022-09-18, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f928e39474c7, moduleTitle=Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f928e39474c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570542, encodeId=aaa215e0542a7, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=Circulation：SGLT2和血管紧张素转换酶抑制剂联合治疗对肾脏和血管的影响, objectType=article, longId=732271, objectId=8eb7e3227136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eb7e3227136, replyNumber=0, likeNumber=42, createdTime=2022-07-14, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eb7e3227136, moduleTitle=Circulation：SGLT2和血管紧张素转换酶抑制剂联合治疗对肾脏和血管的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eb7e3227136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570541, encodeId=901f15e05410c, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=JAMA：高血压患者不应因新冠肺炎因素停止血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂治疗, objectType=article, longId=205952, objectId=e622205952d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e622205952d6, replyNumber=0, likeNumber=36, createdTime=2021-01-22, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e622205952d6, moduleTitle=JAMA：高血压患者不应因新冠肺炎因素停止血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e622205952d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570540, encodeId=10ec15e05402a, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=Hypertension：血管紧张素转换酶抑制剂和他汀类药物对1型糖尿病青少年血管的效应, objectType=article, longId=202568, objectId=1575202568a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1575202568a2, replyNumber=0, likeNumber=28, createdTime=2020-10-29, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1575202568a2, moduleTitle=Hypertension：血管紧张素转换酶抑制剂和他汀类药物对1型糖尿病青少年血管的效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1575202568a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570539, encodeId=45fb15e053959, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=JCEM：血管紧张素转换酶抑制剂减少高血压妇女子宫肌瘤的发病率, objectType=article, longId=202015, objectId=027720201500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=027720201500, replyNumber=0, likeNumber=33, createdTime=2020-10-13, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=027720201500, moduleTitle=JCEM：血管紧张素转换酶抑制剂减少高血压妇女子宫肌瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=027720201500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570538, encodeId=a37e15e0538fe, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=Hypertension：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的结直肠癌风险相关, objectType=article, longId=197196, objectId=31a819e19633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31a819e19633, replyNumber=0, likeNumber=29, createdTime=2020-07-09, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31a819e19633, moduleTitle=Hypertension：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的结直肠癌风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31a819e19633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570537, encodeId=56bd15e0537f3, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的, objectType=article, longId=156150, objectId=0066156150be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0066156150be, replyNumber=0, likeNumber=35, createdTime=2018-12-20, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0066156150be, moduleTitle=J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0066156150be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570536, encodeId=b30315e053644, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, objectType=article, longId=152882, objectId=97e515288294, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97e515288294, replyNumber=0, likeNumber=60, createdTime=2018-11-08, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97e515288294, moduleTitle=J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97e515288294)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570535, encodeId=418815e0535ff, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=BMJ：血管紧张素转换酶抑制剂和肺癌风险, objectType=article, longId=151910, objectId=dc1a1519100e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc1a1519100e, replyNumber=0, likeNumber=34, createdTime=2018-10-27, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc1a1519100e, moduleTitle=BMJ：血管紧张素转换酶抑制剂和肺癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc1a1519100e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570534, encodeId=fb7315e053407, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=JASN：血管紧张素转换酶抑制剂降低蛋白尿可预测CKD患儿肾脏存活情况, objectType=article, longId=142207, objectId=f8a814220eb1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8a814220eb1, replyNumber=0, likeNumber=46, createdTime=2018-07-04, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8a814220eb1, moduleTitle=JASN：血管紧张素转换酶抑制剂降低蛋白尿可预测CKD患儿肾脏存活情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8a814220eb1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570533, encodeId=b0d215e053331, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=NEJM：血管紧张素转换酶抑制剂和他汀类药物不能改善I型糖尿病患者蛋白尿病情进展, objectType=article, longId=118507, objectId=379011850e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379011850e9e, replyNumber=0, likeNumber=37, createdTime=2017-11-04, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379011850e9e, moduleTitle=NEJM：血管紧张素转换酶抑制剂和他汀类药物不能改善I型糖尿病患者蛋白尿病情进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=379011850e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570532, encodeId=178315e0532cf, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=Obstet Gynecol：妊娠早期服用血管紧张素转换酶抑制剂会致畸吗？, objectType=article, longId=84016, objectId=cbf584016af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbf584016af, replyNumber=0, likeNumber=39, createdTime=2016-12-13, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbf584016af, moduleTitle=Obstet Gynecol：妊娠早期服用血管紧张素转换酶抑制剂会致畸吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbf584016af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570531, encodeId=2beb15e0531d5, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=2016血管紧张素转换酶抑制剂在冠心病患者中应用中国专家共识发布, objectType=article, longId=76163, objectId=1a2ae61632d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a2ae61632d, replyNumber=0, likeNumber=22, createdTime=2016-08-31, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a2ae61632d, moduleTitle=2016血管紧张素转换酶抑制剂在冠心病患者中应用中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a2ae61632d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570530, encodeId=471e15e0530e6, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=2016钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议发布, objectType=article, longId=74209, objectId=eea0e420942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eea0e420942, replyNumber=0, likeNumber=19, createdTime=2016-08-03, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eea0e420942, moduleTitle=2016钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eea0e420942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570529, encodeId=704715e0529df, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=JACC：血管紧张素转换酶抑制剂治疗高血压有种族差异, objectType=article, longId=55925, objectId=e8fc559259a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8fc559259a, replyNumber=0, likeNumber=28, createdTime=2015-09-10, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8fc559259a, moduleTitle=JACC：血管紧张素转换酶抑制剂治疗高血压有种族差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8fc559259a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1570528, encodeId=8eb915e05287c, content=<a href='/topic/show?id=d61589e628c' target=_blank style='color:#2F92EE;'>#血管紧张素转换酶抑制剂#</a>, objectTitle=一名肝硬化患者接受血管紧张素转换酶抑制剂/血管紧张素II 受体拮抗剂联合疗法后发生重度肝性脑病：病例报告, objectType=article, longId=2673, objectId=404026e3da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=404026e3da, replyNumber=0, likeNumber=25, createdTime=2011-06-09, rootId=0, userName=chaojitidian, userId=c0c615671800, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=404026e3da, moduleTitle=一名肝硬化患者接受血管紧张素转换酶抑制剂/血管紧张素II 受体拮抗剂联合疗法后发生重度肝性脑病：病例报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=404026e3da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险

2022-09-18

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

Circulation：SGLT2和血管紧张素转换酶抑制剂联合治疗对肾脏和血管的影响

2022-07-14

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

JAMA：高血压患者不应因新冠肺炎因素停止血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂治疗

2021-01-22

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

Hypertension：血管紧张素转换酶抑制剂和他汀类药物对1型糖尿病青少年血管的效应

2020-10-29

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

JCEM：血管紧张素转换酶抑制剂减少高血压妇女子宫肌瘤的发病率

2020-10-13

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

Hypertension：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的结直肠癌风险相关

2020-07-09

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

J INTERN MED：血管紧张素II受体阻断剂对血管紧张素转换酶抑制剂相关的血管神经性水肿患者是安全的

2018-12-20

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

J Aller Cl Imm-Pract：过敏反应与服用β受体阻滞剂和血管紧张素转换酶抑制剂的关系

2018-11-08

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

BMJ：血管紧张素转换酶抑制剂和肺癌风险

2018-10-27

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

JASN：血管紧张素转换酶抑制剂降低蛋白尿可预测CKD患儿肾脏存活情况

2018-07-04

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

NEJM：血管紧张素转换酶抑制剂和他汀类药物不能改善I型糖尿病患者蛋白尿病情进展

2017-11-04

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

Obstet Gynecol：妊娠早期服用血管紧张素转换酶抑制剂会致畸吗？

2016-12-13

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

2016血管紧张素转换酶抑制剂在冠心病患者中应用中国专家共识发布

2016-08-31

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

2016钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议发布

2016-08-03

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

JACC：血管紧张素转换酶抑制剂治疗高血压有种族差异

2015-09-10

chaojitidian (审核中...)

前往app查看评论内容

#血管紧张素转换酶抑制剂#

一名肝硬化患者接受血管紧张素转换酶抑制剂/血管紧张素II 受体拮抗剂联合疗法后发生重度肝性脑病：病例报告

2011-06-09

科室
- - 订阅+
  - 更多科室
工具
服务